[ET Net News Agency, 30 September 2025] WUXI XDC (02268) rose 4.4% to HK$78.4.
It hits an intra-day high of HK$78.6, hitting a historical high, and an intra-day low of HK$75.05. The total shares traded was 2.59 million, with a value of HK$199.03m. The active buy/sell ratio is 51:49, with net buying turnover of HK$4.21m. MORGAN STANLEY HK SEC accounts for greatest net responsive buying turnover of HK$9.54m, with volume weighted average price of HK$77.015. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$11.39m, with volume weighted average price of HK$76.902. The stock has risen a combined 5.2% over the past 2 consecutive trading days.
Basic Information| Nominal | 78.400 | % Chg | +4.39% |
| High | 78.600 | Low | 75.050 |
| Shares Tr | 2.59m | Turnover | 199.03m |
| 10-D SMA | 74.520 | %H.V | 57.250 |
| 20-D SMA | 70.497 | VWAP | 76.906 |
| 50-D SMA | 63.128 | RSI14 | 70.864 |
Status: Hitting a historical high, active buy/sell ratio is 51:49, with net buying turnover of HK$4.21m, rising a combined 5.2% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| WUXI XDC (02268) | 78.40 | +4.39 |
| SINO BIOPHARM (01177) | 8.15 | +1.12 |
| HENGRUI PHARMA (01276) | 87.40 | +3.07 |
| 3SBIO (01530) | 29.98 | -0.53 |
| SKB BIO-B (06990) | 513.50 | +3.61 |
| DUALITYBIO-B (09606) | 366.40 | +2.35 |
| ZAI LAB (09688) | 26.54 | +6.59 |
| AKESO (09926) | 141.60 | +4.97 |
| INNOCARE (09969) | 18.66 | +5.42 |
| REMEGEN (09995) | 118.70 | +5.98 |
(ed)
